NearWave makes a handheld imaging device that helps physicians select the right therapy for their breast cancer patients. This prevents patients from suffering through months of side effects caused by unsuccessful treatments.
NearWave is a breakthrough, non-invasive device utilizing frequency domain near infrared spectroscopy (fdNIRS) to assess vital biomarkers, including tissue oxygen saturation and hemoglobin concentrations.
The NearWave Scanner is currently intended for investigational use only. Pricing details will be available upon commercial release.
NearWave collaborates with universities and hospitals across the country to advance the research and application of fdNIRS technology. Our team is dedicated to bringing cutting-edge diffuse optics science to clinical and research settings.
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS